Sector consensus Novo Nordisk A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 19/09/2024 BST			5-day change	1st Jan Change
898.20 ^DKK	+1.81%		-1.75%	+28.66%

09-18	Hims & Hers offers compounded Wegovy for $99 a month to select professions	RE
09-18	NanoVation Therapeutics Announces Multi-Target Partnership with Novo Nordisk to Develop Genetic Medicines Targeting Cardiometabolic and Rare Diseases	CI

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Ecart obj. / dr	Nbr of analysts
NOVO NORDISK A/S	967.54	+9.67%	26
ELI LILLY AND COMPANY	995.42	+9.99%	25
JOHNSON & JOHNSON	171.32	+3.11%	22
ABBVIE INC.	196.30	+1.74%	27
MERCK & CO., INC.	139.03	+17.18%	26
ROCHE HOLDING AG	301.11	+12.19%	19
ASTRAZENECA PLC	183.54	+17.22%	20
NOVARTIS AG	116.69	+0.65%	20
AMGEN INC.	324.71	-2.47%	24
PFIZER, INC.	33.61	+12.97%	22
SANOFI	112.40	+9.17%	22
GILEAD SCIENCES, INC.	83.54	-0.42%	27
BRISTOL-MYERS SQUIBB COMPANY	53.34	+7.24%	21
GSK PLC	19.70	+22.81%	21
CHUGAI PHARMACEUTICAL CO., LTD	6,663.33	-1.34%	15
DAIICHI SANKYO CO., LTD.	6,541.18	+33.63%	17
HALEON PLC	3.865	-2.59%	17
TAKEDA PHARMACEUTICAL COMPANY LIMITED	4,768.83	+13.35%	18
JIANGSU HENGRUI MEDICINE CO., LTD.	58.20	+28.98%	15
Average	1,143.88	+10.16%	21
Weighted average by Cap.	702.42	+8.91%	23